Glenmark Life Sciences IPO – Schedule *(Final – Pg#311 of RHP)*
22nd July – Announcement of Price Band
26th July – Anchor Investors Allotment
27th July – Offer Opens
29th July – Offer Closes
03rd Aug – Finalisation of Basis of Allotment
04th Aug – Unblocking of ASBA Accounts
05th Aug – Credit of Equity Shares to Depository Accounts
06th Aug – Commencement of Trading
Glenmark Life Sciences IPO – Issue Information *(Final)*
Issue Opens on: 27 July 2021
Issue Closes on: 29 July 2021
Issue Type: Book Built Issue IPO
Issue Size: 2,10,22,222 Shares
Face Value: Rs.2/- per Share
Issue Price: Rs.695 – Rs.720 Share
Discount: NIL
Market Lot: 20 Shares
Listing At: NSE, BSE
Equity Shares outstanding prior to the Issue = 10,78,04,950 Shares
Fresh Issue of 1,47,22,222 Shares @720/- = Rs.1,060.00Crs
Offer for Sale of 63,00,000 Shares @720/- = Rs.453.60Crs
Equity Shares outstanding after the Issue = 12,25,27,172 Shares
Category-wise Break up:
Anchor – 63,06,667 Shares = 454.08Crs
QIB – 42,04,444 Shares = 302.72Crs
NII – 31,53,333 Shares = 227.04Crs
RII – 73,57,778 Shares = 529.76Crs (Lot size: 20 = 3,67,889 Forms)
Total Issue – 2,10,22,222 Shares = 1513.60Crs.
Subscription required for 1X
RII = 3,67,889 Forms
NII = 227.04Crs
Glenmark Life Sciences IPO – Financial Information (Basis of Valuation)
The information is collated from the following documents:
1) RHP = Red Herring Prospectus Dated July 19, 2021 (358 pages)
EPS for FY18-19 >>> Rs.24.64 (Page #82 of RHP)
EPS for FY19-20 >>> Rs.29.04 (Page #82 of RHP)
EPS for FY20-21 >>> Rs.32.61 (Page #82 of RHP)
RoNW for FY18-19 >>> 99.25% (Page #83 of RHP)
RoNW for FY19-20 >>> 77.94% (Page #83 of RHP)
RoNW for FY20-21 >>> 46.71% (Page #83 of RHP)
NAV as on March 31, 2021 was Rs.69.82 (Page #83 of RHP)
Listed Industry Peer Group (Page #83 of RHP): Divis Laboratories, Laurus Labs, Shilpa Medicare, Aarti Drugs, Solara Active Pharma Sciences
Glenmark Life Sciences IPO – *Market’s Current Estimates of oversubscription*:
NII = 50KCrs. = ~220.23X
RII = 32.50L Forms = 8.83X Applic. wise (Avg allotment of ~2.26 shares per lot)
Interest cost *@8.00%p.a.* for 7days = *110.47 paise for 1X*
Thus, for NII the costing = 220.23 X 110.47 paise = Rs.243.27 per share (= GMP)
And, for RII the costing = 243.27 X 2.26 = Rs.551/- (= Kostak)
Glenmark Life Sciences IPO – *GMP Estimated*
GMP 250 +/- 2
Kostak 565 +/- 10
Subject 2 @4,250/-